Generic Name and Formulations:
Diphenhydramine HCl 25mg; tabs.
Company:
GlaxoSmithKline Pharmaceuticals
Short-term (≤ 2 weeks) treatment of insomnia.
50mg at bedtime.
Not recommended.
Hypnotic (anticholinergic).
Asthma. Lower respiratory disorders. Glaucoma. Hyperthyroidism. Hypertension. Cardiovascular disease. GI or urinary obstruction. Pregnancy. Nursing mothers.
Potentiates CNS depression with alcohol, other CNS depressants. Concomitant diphenhydramine products (including topicals): not recommended. Additive effects with other other anticholinergics.
Drowsiness, dizziness, anticholinergic effects, paradoxical excitement.
Original (tabs)—16, 32, 72
Max Strength (caplets)—16